Cargando…

Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria

BACKGROUND: Despite the widespread use and availability of rapidly acting anti-malarials, the fatality rate of severe malaria in sub-Saharan Africa remains high. Adjunctive therapies that target the host response to malaria infection may further decrease mortality over that of anti-malarial agents a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varo, Rosauro, Crowley, Valerie M., Sitoe, Antonio, Madrid, Lola, Serghides, Lena, Bila, Rubao, Mucavele, Helio, Mayor, Alfredo, Bassat, Quique, Kain, Kevin C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442675/ https://www.ncbi.nlm.nih.gov/pubmed/28535809 http://dx.doi.org/10.1186/s12936-017-1858-0

Ejemplares similares

Adjunctive therapy for severe malaria: a review and critical appraisal
por: Varo, Rosauro, et al.
Publicado: (2018)

Continuous Glucose Monitoring in Resource-Constrained Settings for Hypoglycaemia Detection: Looking at the Problem from the Other Side of the Coin
por: Bila, Rubao, et al.
Publicado: (2018)

Continuous determination of blood glucose in children admitted with malaria in a rural hospital in Mozambique
por: Madrid, Lola, et al.
Publicado: (2017)

Malaria, immunity and mental disorders: A plausible relationship?
por: Varo, Rosauro, et al.
Publicado: (2019)

Plasma MicroRNA Profiling of Plasmodium falciparum Biomass and Association with Severity of Malaria Disease
por: Gupta, Himanshu, et al.
Publicado: (2021)

Clinical trials to assess adjuvant therapeutics for severe malaria
por: Varo, Rosauro, et al.
Publicado: (2020)

Opportunities for Improving Outcomes in Severe Malaria: The Role of Blood Glucose Monitoring
por: Torres-Fernandez, David, et al.
Publicado: (2023)

Serial lung ultrasounds in pediatric pneumonia in Mozambique and Pakistan
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021)

The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
por: Bassat, Quique
Publicado: (2011)

Highlighting the burden of malarial infection and disease in the neonatal period: making sense of different concepts
por: Nhama, Abel, et al.
Publicado: (2020)

Host-Based Prognostic Biomarkers to Improve Risk Stratification and Outcome of Febrile Children in Low- and Middle-Income Countries
por: Balanza, Núria, et al.
Publicado: (2020)

Performance of lung ultrasound in the diagnosis of pediatric pneumonia in Mozambique and Pakistan
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020)

“Resistance” to diagnostics: A serious biological challenge for malaria control and elimination
por: Mayor, Alfredo, et al.
Publicado: (2019)

The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria
por: Serghides, Lena
Publicado: (2012)

Tying malaria and microRNAs: from the biology to future diagnostic perspectives
por: Rubio, Mercedes, et al.
Publicado: (2016)

Klebsiella spp. cause severe and fatal disease in Mozambican children: antimicrobial resistance profile and molecular characterization
por: Massinga, Arsénia J., et al.
Publicado: (2021)

Prognostic accuracy of biomarkers of immune and endothelial activation in Mozambican children hospitalized with pneumonia
por: Balanza, Núria, et al.
Publicado: (2023)

Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants
por: Gargano, Nicola, et al.
Publicado: (2017)

In vivo efficacy and safety of artemether–lumefantrine and amodiaquine–artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018
por: Nhama, Abel, et al.
Publicado: (2021)

Plasmodium falciparum sexual conversion rates can be affected by artemisinin-based treatment in naturally infected malaria patients
por: Portugaliza, Harvie P., et al.
Publicado: (2022)

Congenital cytomegalovirus, parvovirus and enterovirus infection in Mozambican newborns at birth: A cross-sectional survey
por: Madrid, Lola, et al.
Publicado: (2018)

The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysis
por: Mousa, Andria, et al.
Publicado: (2020)

Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria
por: Bassat, Quique, et al.
Publicado: (2022)

Positive direct antiglobulin test in post-artesunate delayed haemolysis: more than a coincidence?
por: Camprubí, Daniel, et al.
Publicado: (2019)

Efficacy and Safety of Artemether-Lumefantrine in the Treatment of Acute, Uncomplicated Plasmodium falciparum Malaria: A Pooled Analysis
por: Makanga, Michael, et al.
Publicado: (2011)

Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial
por: Bassat, Quique, et al.
Publicado: (2009)

Community-informed research on malaria in pregnancy in Monrovia, Liberia: a grounded theory study
por: Tarr-Attia, Christine K., et al.
Publicado: (2018)

Similar efficacy and safety of artemether-lumefantrine (Coartem(®)) in African infants and children with uncomplicated falciparum malaria across different body weight ranges
por: Bassat, Quique, et al.
Publicado: (2011)

Field performance of ultrasensitive and conventional malaria rapid diagnostic tests in southern Mozambique
por: Galatas, Beatriz, et al.
Publicado: (2020)

Making sense of emerging evidence on the non-specific effects of the BCG vaccine on malaria risk and neonatal mortality
por: Bassat, Quique, et al.
Publicado: (2020)

C5a Enhances Dysregulated Inflammatory and Angiogenic Responses to Malaria In Vitro: Potential Implications for Placental Malaria
por: Conroy, Andrea, et al.
Publicado: (2009)

Approaching the Target: the Path Towards an Effective Malaria Vaccine
por: García-Basteiro, Alberto L., et al.
Publicado: (2012)

Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria
por: Van Malderen, Carine, et al.
Publicado: (2012)

PPARγ Agonists Improve Survival and Neurocognitive Outcomes in Experimental Cerebral Malaria and Induce Neuroprotective Pathways in Human Malaria
por: Serghides, Lena, et al.
Publicado: (2014)

Inhaled Nitric Oxide Reduces Endothelial Activation and Parasite Accumulation in the Brain, and Enhances Survival in Experimental Cerebral Malaria
por: Serghides, Lena, et al.
Publicado: (2011)

Association of Severe Malaria Outcomes with Platelet-Mediated Clumping and Adhesion to a Novel Host Receptor
por: Mayor, Alfredo, et al.
Publicado: (2011)

Getting ready for malaria elimination: a check list of critical issues to consider
por: González-Silva, Matiana, et al.
Publicado: (2014)

HIV Impairs Opsonic Phagocytic Clearance of Pregnancy-Associated Malaria Parasites
por: Keen, Jessica, et al.
Publicado: (2007)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

‘Researchers have love for life’: opportunities and barriers to engage pregnant women in malaria research in post-Ebola Liberia
por: Martínez Pérez, Guillermo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sv1ht2afl56dju71ro2ueesqva